|
Status
|
In progress
|
|
Decision
|
Selected
|
| Process |
TA
|
| ID number |
858
|
Project Team
Email enquiries
| External Assessment Group |
Peninsula Technology Assessment Group (PenTAG), University of Exeter |
Stakeholders
| Companies sponsors |
Novartis (everolimus) |
| |
Pfizer (sunitinib) |
| Others |
Department of Health |
| |
NHS England |
| |
Welsh Government |
| Patient carer groups |
The NET Patient Foundation |
| Professional groups |
British Institute of Radiology |
| |
British Nuclear Medicine Society |
| |
Cancer Research UK |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Comparator companies |
Accord Healthcare (CAU not returned, not participating) |
| |
Allergan UK (CAU not returned, not participating) |
| |
Hospira UK (CAU not returned, not participating) |
| |
Janssen (CAU not returned, not participating) |
| |
medac GmBH (CAU not returned, not participating) |
| |
Merck Sharp and Dohme (CAU not returned, not participating) |
| |
Novartis (octreotide long acting release) |
| |
Pfizer (doxorubicin) |
| |
Roche Products (CAU not returned, not participating) |
| |
Sun Pharmaceuticals UK (CAU not returned, not participating) |
| |
Teva Pharma (CAU not returned, not participating) |
| General commentators |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Institute of Cancer Research |
|
Date
|
Update
|
|
28 June 2017
|
Expected publication |
|
14 June 2017
|
The scope for this technology appraisal included lutetium-177 dotatate (177Lu-dotatate). NICE cannot release any recommendations on 177Lu-dotatate until it has a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use. A separate document with the committee’s recommendations will be released when this opinion is received. Information about this separate document can be found on the NICE website. |
|
12 May 2017 - 26 May 2017
|
Final appraisal determination |
|
28 February 2017
|
Committee meeting: 1 |
|
25 May 2016
|
Invitation to participate |
|
22 February 2016
|
Draft scope documents |
|
04 November 2015
|
Referral |
For further information on our processes and methods, please see our CHTE processes and methods manual